Exidot 80 mg Spot-on solution for Large Cats and Large Pet Rabbits

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Viambatanisho vya kazi:

Imidacloprid

Inapatikana kutoka:

Chanelle Pharmaceuticals Manufacturing Limited

ATC kanuni:

QP53AX17

INN (Jina la Kimataifa):

Imidacloprid

Kipimo:

80 mg/pipette

Dawa fomu:

Spot-on solution

Dawa ya aina:

POM: Prescription Only Medicine as defined in relevant national legislation

Eneo la matibabu:

imidacloprid

Idhini hali ya:

Authorised

Idhini ya tarehe:

2019-11-15

Tabia za bidhaa

Health Products Regulatory Authority
19 November 2019
CRN000XMS
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Exidot 80 mg Spot-on solution for Large Cats and Large Pet Rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each 0.8 ml pipette contains:
​
​
​
ACTIVE SUBSTANCE:
​
​
​
Imidacloprid
​80
​
mg
​
EXCIPIENTS:
​
​
​
Butylhydroxytoluene (E 321)
​0.8
​
mg
​
For the full list of excipients, see section 6.1.
​
​
3 PHARMACEUTICAL FORM
Spot-on solution
A clear pale yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and pet rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For cats of 4 kg and greater:
Prevention and treatment of flea (_Ctenocephalides felis_)
infestations.
For pet rabbits of 4 kg and greater:
Treatment of flea infestations.
Fleas are killed within one day following treatment.
One treatment prevents further flea infestation for three to four
weeks on cats and up to one week on pet rabbits.
The product can be used as part of a treatment strategy for the
control of Flea Allergy Dermatitis (FAD) in cats, where this has
been previously diagnosed by a veterinary surgeon.
4.3 CONTRAINDICATIONS
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use on pet rabbits of less than 10 weeks of age.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Re-infestation from emergence of new fleas in the environment may
continue to occur for six weeks or longer after treatment
is initiated. More than one treatment may therefore be required,
depending on the level of fleas in the environment. To aid
reduction in environmental challenge, the additional use of a suitable
environmental treatment against adult fleas and their
developing stages is recommended. In order to reduce further the
environmental challenge, it is recommended that all cats
and pet rabbits in the household are treated. Treatment of nursing
queens